lansoprazole has been researched along with Brain Diseases in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulliat, J | 1 |
| Polard, E | 1 |
| Colin, F | 1 |
| Bentué-Ferrer, D | 1 |
| Allain, H | 1 |
1 other study available for lansoprazole and Brain Diseases
| Article | Year |
|---|---|
[Myoclonic encephalopathy associated with proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Brain Diseases; Humans; Lansoprazole; Myoclonus; Omeprazole | 2004 |